A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Clinical trial NCT03299738 · UNKNOWN

Trial details

NCT number: NCT03299738
Sponsor: Shanghai AbelZeta Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma

Start date: 2017-12-01
Primary completion: 2018-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.